Category: January 2026

  • NHI Legal Challenges: Talks Stalled by Politics, Funding Gaps

    Finance Minister Enoch Godongwana’s call in Parliament to withdraw the nine National Health Insurance (NHI) lawsuits and pursue negotiations hinted at a reset. The NHI legal challenges highlight complex debates over the future of healthcare in South Africa. Some stakeholders, including Profmed’s Craig Comrie, signalled openness to talks to avoid appearing anti-poor. Yet beneath the courtesy lies hard calculus: most…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • NHI Legal Challenges: Minister Calls For Out‑Of‑Court Resolution

    Finance Minister Enoch Godongwana used the National Assembly’s adjustments appropriation debate to make a firm appeal. He asked that legal disputes over the National Health Insurance (NHI) Act be resolved outside the courts. His comments came as medical associations pursue at least five separate legal cases challenging the NHI framework and implementation. Godongwana said that while these groups claim to…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • US Healthcare Spending Rose Sharply to $5.3 Trillion in 2024

    Healthcare costs in the United States surged to $5.3 trillion in 2024. This marked a 7.2% increase from $4.9 trillion in 2023, according to new data released by the Centers for Medicare & Medicaid Services (CMS). Moreover, the CMS report reveals that this growth was primarily driven by higher insurance enrolment and a sharp increase in the use of medical…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Aspen Pharmacare Business Sale Sparks Investor Optimism

    Aspen Pharmacare faced a turbulent 2025 marked by a severe earnings downgrade and shaken investor trust. In early 2025, Aspen announced that EBITDA for the financial year would be R2 billion below prior guidance. This surprise came just weeks after the company’s interim results, catching markets off guard and sending its share price plummeting by more than 30%. The earnings…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Hospital-Acquired Infections Lack National Tracking

    South Africa lacks a national database to track hospital-acquired infections (HAIs), leaving a critical gap in patient safety and infection control. Health experts warn that the absence of systematic surveillance allows preventable infections and deaths to go unnoticed, particularly among vulnerable groups such as newborns and mothers. A 2024 study, The Burden of Hospital-Acquired Infections (HAI) in Sub-Saharan Africa, revealed…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Discovery Health Claims Reversal follows member outcry

    Discovery Health Medical Scheme (DHMS) has reversed its controversial decision regarding claims overpayments. The administrator will now cover the costs after sustained member outcry and mounting public pressure. This marks a significant shift in strategy. The provision protects members on the scheme’s high-end plans Impact of Discovery Health Claims Processing Errors The issue centres on a processing mistake. This error…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • European Drug Pricing Dispute Escalates Over US Deals

    Global pharmaceutical companies are entering 2026 facing a high-stakes European drug pricing dispute as they seek to offset recent price concessions in the United States. Following intense pressure from President Donald Trump, who secured major drug price cuts for American patients in late 2025, companies are now turning to Europe to recoup revenue losses. Manufacturers such as Pfizer, Eli Lilly, and AstraZeneca have…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Discovery Health Claims Error Triggers Outrage Over Oversight

    A year-long administrative failure at Discovery Health Medical Scheme (DHMS) has sparked mounting frustration among members, as the scheme begins recovering erroneous payments from policyholders. The Discovery Health claims error, which went undetected for 12 months, has affected an estimated 16,000 members across five high-end plans. The administrator, Discovery Health, is now requesting repayment of substantial amounts, some exceeding R68,000.…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • GEMS Tariff Intervention Underway Amid Affordability Concerns

    The South African government has stepped into the controversy surrounding sharp increases in contributions to the Government Employees Medical Scheme (GEMS). Public Service and Administration Minister Mzamo Buthelezi told Parliament that officials will engage with GEMS trustees regarding what he called “unaffordable tariffs.” This follows a 9.8% hike in GEMS member contributions this year, on top of a 13.4% increase…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in